Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology
Frontiers in Pharmacology · 10.05.2023 · 14
DOI: 10.3389/fphar.2023.940129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.05.2023. Verfasst von Sanjay Pandey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pathogen-associated molecular patterns (PAMPs) like bacterial cell wall components and viral nucleic acids are known ligands of innate inflammatory receptors that trigger multiple inflammatory pathways that may result in acute inflammation and oxidative stress-driven tissue and organ toxicity. When dysregulated, this inflammation may lead to acute toxicity and multiorgan failure. Inflammatory events are often driven by high energy demands and macromolecular biosynthesis. Therefore, we proposed that targeting the metabolism of lipopolysaccharide (LPS)-driven inflammatory events, using an energy restriction approach, can be an effective strategy to prevent the acute or chronic detrimental effects of accidental or seasonal bacterial and other pathogenic exposures. In the present study, we investigated the potential of energy restriction mimetic agent (ERMA) 2-deoxy-D-glucose (2-DG) in targeting the metabolism of inflammatory events during LPS-elicited acute inflammatory response. Mice fed with 2-DG as a dietary component in drinking water showed reduced LPS-driven inflammatory processes. Dietary 2-DG reduced LPS-induced lung endothelial damage and oxidative stress by strengthening the antioxidant defense system and limiting the activation and expression of inflammatory proteins, viz., P-Stat-3, NfκΒ, and MAP kinases. This was accompanied by decreased TNF, IL-1β, and IL-6 levels in peripheral blood and bronchoalveolar lavage fluid (BALF). 2-DG also reduced the infiltration of PMNCs (polymorphonuclear cells) in inflamed tissues. Altered glycolysis and improved mitochondrial activity in 2-DG-treated RAW 264.7 macrophage cells suggested possible impairment of macrophage metabolism and, therefore, activation in macrophages. Taken together, the present study suggests that inclusion of glycolytic inhibitor 2-DG as a part of the diet can be helpful in preventing the severity and poor prognosis associated with inflammatory events during bacterial and other pathogenic exposures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi, India.
- Infectious Disease Immunology Laboratory, Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India.
- Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, NY, United States.
Zitieren
APA
Pandey, S., Anang, V., Singh, S., Seth, S., Bhatt, A. N., Kalra, N., Manda, K., Soni, R., Roy, B. G., Natarajan, K., & Dwarakanath, B. S. (2023). Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.940129
Vancouver
Pandey S, Anang V, Singh S, Seth S, Bhatt AN, Kalra N, et al. Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.940129
BibTeX
@article{Pandey2023,
author = {Pandey, Sanjay and Anang, Vandana and Singh, Saurabh and Seth, Saurabh and Bhatt, Anant Narayan and Kalra, Namita and Manda, Kailash and Soni, Ravi and Roy, Bal Gangadhar and Natarajan, K and Dwarakanath, Bilikere S},
title = {Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.940129}
}
EUVIMED